Lymphoma. Hodgkinlymfomen and non-Hodgkin's disease

Information on current developments in both regular and alternative or complementary treatments and resources for lymphoma - non-Hodgkin's lymphoma and Hodgkin's disease at all stages.

Recent articles in left column more or less in alphabetical order classified

Experiences of cancer patients with complementary approaches can be found by experience stories on our website and there are also some videos of experiences of cancer patients with complementary approaches to see. To click on video button top left of this page. Or visit the website of the SNFK information where movies are shown on complementary approaches to cancer.

If you want to support us you can do so through a donation: See registration OPS

Chemo and radiation for lymphoma - Non-Hodgkin and Hodgkin's disease - gives high risk for future new forms of cancer. In young women, 136 times greater risk of breast cancer such reports in the Lancet study says. Update November 27, 2010

Source: the Lancet dated April 5, 2003:

"Saturday, April 5, 2003 is an article in the Lancet on the effects of chemo and radiation for Hodgkin's disease and non-Hodgkin. This treatment often causes new cancers and new forms of cancer. Treated 136 such women are twice as likely as normal to develop breast cancer. The authors of the study argue for less aggressive treatment of Hodgkin's. (JV)

Below the abstract of the article in the Lancet and below the abstract of a study that proves that women are 136 times more likely to have breast cancer after treatment with chemotherapy and radiation for lymphoma. What I do remarkable find is that if a mouse cured with a new form of chemo this on the front pages of all newspapers widely publicized, especially when the leading Lancet this post, now this message to my knowledge, not a single newspaper or medium mentioned. Talk about selective reporting.

Source: the Lancet dated April 5, 2003:

"The incidence of second malignant growths - include haematological cancers and solid tumoren - HAS emerged as a serious long-term effects of therapy for Hodgkin's disease '

Hodgkin's disease is a success story for cancer treatment. Use of intensive radiotherapy and chemotherapy regimens HAS ensured That More Than 85% of Patients of Their disease are cured. However, development of secondary cancers is a serious long-term side-effects of treatment - Women Treated for Hodgkin's disease have a risk of breast cancer Developing up to 136 Times Higher Than That of the general population. In the April issue of The Lancet Oncology, Kenan Deniz and colleagues discuss a protocol for formal follow-up of Patients Treated for Hodgkin's disease. They describe treatment options That Avoid the necessity for high-dose radiotherapy, and review the unique Characteristics of treatment-induced breast cancers Which Should Aid Development of effective management strategies for thesis patiënten.


Lancet Oncol 2003, 4: 207-14


Breast cancer in women after treatment for Hodgkin's disease
Kenan Deniz a, a Susan O'Mahony, Gillian Ross b, a and Anand Purushotham

-------------------------------------------------- ------------------------------

Summary
Although Substantial Progress Has Been Made in the management of Hodgkin's lymphoma consistently the Past 30 years, the development of secondary malignant diseases HAS emerged as a serious conséquence or treatment. In Particular, extended follow-up of Patients with Hodgkin's disease revealed an HAS Increased risk of breast cancer. We have systematically reviewed all published literature on breast cancer after treatment for Hodgkin's disease and show That Particularly high risk is associated with treatment at a young age, mantle radiotherapy, and chemotherapy. Breast cancers in this context difference from Sporadic disease becauses They initially develop in younger women, are associated with a high incidence of bilateral disease, and gene rally are located near the midline of the body. The risk of breast cancer is lower in patient who receive newer, combined modality treatments for Hodgkin's disease. In this review we discuss a formal protocol for screening and follow-up of Patients who have recovered from Hodgkin's disease to aid early diagnosis and ENSURE The Possibility of effective management.

-------------------------------------------------- ------------------------------

Affiliations:
a KD SO'M, and AP are at the Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK. b GR at the Royal Marsden Hospital, London, UK.